The independent source for health policy research, polling, and news.
1,161-1,180 of 3,578 results
As he takes the reins of the Senate Health, Education, Labor & Pensions Committee, the independent from Vermont and implacable champion of “Medicare for All” maps out his strategy for negotiating with Republicans — and Big Pharma.
The 2018 farm bill that legalized hemp created a loophole for an unregulated copycat of marijuana. A form of delta-9 THC — the psychoactive substance in pot — doesn’t face the same laws and regulations as marijuana because it comes from hemp. The drug is poised to upend the cannabis industry.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In Texas, many people have a right to mediation of medical bills. But the concept can be off-putting, and patients often think they need a lawyer, which isn't the case.
Vasectomies can cost hundreds of dollars out-of-pocket — or more. State lawmakers are debating whether to make the procedure free to millions of men.
The Biden administration has decided to try to fix the so-called “family glitch” in the Affordable Care Act without an act of Congress. The provision has prevented workers’ families from getting subsidized coverage if an employer offer is unaffordable. Meanwhile, Medicare’s open enrollment period begins Oct. 15, and private Medicare Advantage plans are poised to cover more than half of Medicare’s 65 million enrollees. Margot Sanger-Katz of The New York Times, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read.
Applicants for cash, food, and health care assistance would need to go to court to appeal rejections if the Montana legislature approves a proposal to eliminate the Board of Public Assistance.
Nonprofit RIP Medical Debt buys up unpaid hospital bills plaguing low-income patients and frees them from having to pay.
In Part II of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also, for extra credit, the panelists recommend their most memorable reproductive health stories from the last year.
Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses, in deals almost always hidden from federal regulators. The result: higher prices, lawsuits, and complaints about care.
The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.
With prices of necessities rising dramatically, many older Americans are having trouble making ends meet. They often don’t know that help is available from a variety of programs, and some sources of financial assistance are underused.
Abortion isn’t the only health issue voters will be asked to decide in state ballot questions next month. Proposals about medical debt, Medicaid expansion, and whether health care should be a right are on ballots in various states. Meanwhile, the latest lawsuit challenging the Affordable Care Act has expanded to cover all preventive care. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more.
Pharmacy benefit managers, or PBMs, are companies that negotiate the prices of prescription drugs. Hear about their role in raising drug prices and the ongoing efforts to regulate this complex industry.
Public transit is already insufficient in rural areas, leaving residents with few options as they travel greater distances to access health care. But older residents who depend on volunteer drivers to get them to appointments face another challenge: The number of those volunteers is declining.
Medical debt is most prevalent in the Southeast, where states have not expanded Medicaid and have few consumer protection laws. Now, North Carolina is considering two bills that could change that, making the state a leader in protecting patients from high medical bills.
The Supreme Court is considering the future of the abortion pill mifepristone, after GenBioPro sued the FDA over limitations that effectively block generic production of the drug, a major part of the market. Congress is considering proposals that would impose Medicaid work requirements, crack down on pharmacy benefit managers, and more. And President Joe Biden moved to expand health coverage to young immigrants known as “Dreamers.” Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Mary Agnes Carey to discuss these issues and more.
KHN gives readers a chance to comment on a recent batch of stories.
© 2026 KFF